missing translation for 'onlineSavingsMsg'
Learn More

Tirbanibulin, MedChemExpress

Product Code. 16474876
Encompass_Preferred
Click to view available options
Menge:
5 mg
10 mg
50 mg
100 mg
Unit Size:
10 Milligramm
100 Milligramm
5 Milligramm
50 Milligramm
This item is not returnable. View return policy

Product Code. 16474876

Brand: Medchem Express HY10340

om dit product te kopen Registreer vandaag om een webaccount aan te maken

This item is not returnable. View return policy

MedChemExpress Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

Specifications

Chemischer Name oder Material Tirbanibulin
CAS 897016-82-9
Farbe White
Hinweise zur Reinheitsqualität Research
Summenformel C26H29N3O3
Menge 100 mg
Synonym KX2-391 KX-01
Löslichkeitsinformationen DMSO : 41.67 mg/mL (96.56 mM; Need ultrasonic)
SMILES O=C(CC1=NC=C(C2=CC=C(OCCN3CCOCC3)C=C2)C=C1)NCC4=CC=CC=C4
Molekulargewicht (g/mol) 431.53
Formelmasse 431.53
Reinheit (%) 99.33%
Güte Research
Physikalische Form Solid
Zur Verwendung mit (Anwendung) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.